Clinical Research Directory
Browse clinical research sites, groups, and studies.
Summary
The goal of this clinical trial is to determine the serum ferritin level and hematocrit level in very preterm infants receiving donor breast milk(DBM) with an early iron supplementation protocol . The main questions it aims to answer are: Does earlier iron supplementation provide increased ferritin levels at 14 and 28 days of life in subjects fed primarily donor breast milk? Iron supplementation will be implemented when the infant achieves 80ml/kg/day of enteral feeds, as contrasted to the current protocol of full feeds (140 to 160ml/kg/day), the latter usually by Day 14 of life. At day of life(DOL) 14 (± 4 days), a blood sample will be obtained for serum ferritin determination. Similarly, a second blood draw would be performed at day of life 28 (± 4 days) or prior to discharge, whichever comes earlier
Official title: Early Iron Supplementation in Very Preterm Infants Fed Donor Breast Milk: A Prospective, Interventional, Clinical Trial
Key Details
Gender
All
Age Range
29 Weeks - 33 Weeks
Study Type
INTERVENTIONAL
Enrollment
17
Start Date
2026-05-06
Completion Date
2027-12
Last Updated
2026-09-11
Healthy Volunteers
No
Conditions
Interventions
Ferrous Sulfate Oral Product
Dietary Supplement
Locations (1)
AdventHealth Orlando
Orlando, Florida, United States